EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 325-332

  Clapéron, Audrey ^a,b   Mergey, Martine ^a,b   Nguyen Ho Bouldoires, Thanh Huong ^a,b   Vignjevic, Danijela ^c   Wendum, Dominique ^a,b,d   Chrétien, Yves ^a,b   Merabtene, Fatiha ^a   Frazao, Alexandra ^a,b   Paradis, Valérie ^e   Housset, Chantal ^a,b   Guedj, Nathalie ^e   Fouassier, Laura ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT CURIE   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e INSERM   (France)

Author keywords

Cholangiocarcinoma; E cadherin; EGF; EGFR; Invasion; Migration

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; CADHERIN; EGFR PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER SIZE; CELL DISRUPTION; CELL INVASION; CELL JUNCTION; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT; ANIMAL; BILE DUCT TUMOR; CELL MOTION; DISEASE COURSE; FEMALE; INTRAHEPATIC BILE DUCT; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICE; NEOPLASM INVASIVENESS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84904741452     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.03.033     Document Type: Article

References (39)

1. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
2. M. Guarino, B. Rubino, and G. Ballabio The role of epithelial-mesenchymal transition in cancer pathology Pathology 39 2007 305 318
3. D. Firrincieli, M. Boissan, and N. Chignard Epithelial-mesenchymal transition in the liver Gastroenterol Clin Biol 34 2010 523 528
4. B. De Craene, and G. Berx Regulatory networks defining EMT during cancer initiation and progression Nat Rev Cancer 13 2013 97 110
5. N. Razumilava, and G.J. Gores Cholangiocarcinoma Lancet 2014 10.1016/S0140-6736(13)61903-0
6. H.S. Ryu, J.H. Chung, K. Lee, E. Shin, J. Jing, and G. Choe et al. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma Hum Pathol 43 2012 2360 2370
7. L. Fabris, M. Cadamuro, L. Moserle, J. Dziura, X. Cong, and L. Sambado et al. Nuclear expression of S100A4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization Hepatology 54 3 2011 890 899
8. X. Yao, X. Wang, Z. Wang, L. Dai, G. Zhang, and Q. Yan et al. Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma Onco Targets Ther 5 2012 255 261
9. P.V. Korita, T. Wakai, Y. Ajioka, M. Inoue, M. Takamura, and Y. Shirai et al. Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma Anticancer Res 30 2010 2279 2285
10. K.J. Zhang, B.Y. Zhang, K.P. Zhang, L.M. Tang, S.S. Liu, and D.M. Zhu et al. Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma World J Gastroenterol 16 2010 2554 2557
11. A. Dos Santos, M. Court, V. Thiers, S. Sar, C. Guettier, and D. Samuel et al. Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics Mol Cell Proteomics 9 2010 1991 2004
12. J.F. Mosnier, C. Kandel, D. Cazals-Hatem, C. Bou-Hanna, J. Gournay, and A. Jarry et al. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas Mod Pathol 22 2009 182 190
13. E.S. Henson, and S.B. Gibson Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy Cell Signal 18 2006 2089 2097
14. S. Sebastian, J. Settleman, S.J. Reshkin, A. Azzariti, A. Bellizzi, and A. Paradiso The complexity of targeting EGFR signalling in cancer: from expression to turnover Biochim Biophys Acta 1766 2006 120 139
15. S. Barr, S. Thomson, E. Buck, S. Russo, F. Petti, and I. Sujka-Kwok et al. Bypassing cellular EGF receptor dependence through epithelial-to- mesenchymal-like transitions Clin Exp Metastasis 25 2008 685 693
16. D. Yoshikawa, H. Ojima, M. Iwasaki, N. Hiraoka, T. Kosuge, and S. Kasai et al. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma Br J Cancer 98 2008 418 425
17. J.H. Yoon, G.Y. Gwak, H.S. Lee, S.F. Bronk, N.W. Werneburg, and G.J. Gores Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells J Hepatol 41 2004 808 814
18. A. Claperon, N. Guedj, M. Mergey, D. Vignjevic, C. Desbois-Mouthon, and M. Boissan et al. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells Oncogene 31 2012 1376 1388
19. Y. Ito, T. Takeda, Y. Sasaki, M. Sakon, T. Yamada, and S. Ishiguro et al. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma Pathol Res Pract 197 2001 95 100
20. J. Harder, O. Waiz, F. Otto, M. Geissler, M. Olschewski, and B. Weinhold et al. EGFR and HER2 expression in advanced biliary tract cancer World J Gastroenterol 15 2009 4511 4517
21. A. Nonomura, G. Ohta, Y. Nakanuma, R. Izumi, Y. Mizukami, and F. Matsubara et al. Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method Liver 8 1988 157 166
22. D. Sia, Y. Hoshida, A. Villanueva, S. Roayaie, J. Ferrer, and B. Tabak et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes Gastroenterology 144 2013 829 840
23. A. Claperon, M. Mergey, L. Aoudjehane, T.H. Ho-Bouldoires, D. Wendum, and A. Prignon et al. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor Hepatology 58 6 2013 2001 2011
24. J.C. Cheng, N. Auersperg, and P.C. Leung EGF-induced EMT and invasiveness in serous borderline ovarian tumour cells: a possible step in the transition to low-grade serous carcinoma cells? PLoS One 7 2012 e34071
25. D.J. Webb, K. Donais, L.A. Whitmore, S.M. Thomas, C.E. Turner, and J.T. Parsons et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly Nat Cell Biol 6 2004 154 161
26. T.B. Deramaudt, D. Dujardin, A. Hamadi, F. Noulet, K. Kolli, and J. De Mey et al. FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion Mol Biol Cell 22 2011 964 975
27. J.E. Bear, T.M. Svitkina, M. Krause, D.A. Schafer, J.J. Loureiro, and G.A. Strasser et al. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility Cell 109 2002 509 521
28. J.B. Andersen, B. Spee, B.R. Blechacz, I. Avital, M. Komuta, and A. Barbour et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors Gastroenterology 142 2012 e1015
29. D. Sia, V. Tovar, A. Moeini, and J.M. Llovet Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies Oncogene 32 41 2013 4861 4870
30. L.G. Komuves, A. Feren, A.L. Jones, and E. Fodor Expression of epidermal growth factor and its receptor in cirrhotic liver disease J Histochem Cytochem 48 2000 821 830
31. Z. Lu, S. Ghosh, Z. Wang, and T. Hunter Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumour cell invasion Cancer Cell 4 2003 499 515
32. E. Sanchez-Tillo, Y. Liu, O. de Barrios, L. Siles, L. Fanlo, and M. Cuatrecasas et al. EMT-activating transcription factors in cancer: beyond EMT and tumour invasiveness Cell Mol Life Sci 69 2012 3429 3456
33. Y. Adachi, T. Takeuchi, T. Nagayama, Y. Ohtsuki, and M. Furihata Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer FEBS Lett 583 2009 430 436
34. N. Oishi, M.R. Kumar, S. Roessler, J. Ji, M. Forgues, and A. Budhu et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma Hepatology 56 2012 1792 1803
35. E. Sanchez-Tillo, L. Siles, O. de Barrios, M. Cuatrecasas, E.C. Vaquero, and A. Castells et al. Expanding roles of ZEB factors in tumorigenesis and tumour progression Am J Cancer Res 1 2011 897 912
36. D. Vignjevic, and G. Montagnac Reorganisation of the dendritic actin network during cancer cell migration and invasion Semin Cancer Biol 18 2008 12 22
37. A.M. Weaver Cortactin in tumour invasiveness Cancer Lett 265 2008 157 166
38. U. Pongchairerk, J.L. Guan, and V. Leardkamolkarn Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1 World J Gastroenterol 11 2005 5845 5852
39. N.N. Mon, H. Hasegawa, A.A. Thant, P. Huang, Y. Tanimura, and T. Senga et al. A role for focal adhesion kinase signaling in tumour necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1 Cancer Res 66 2006 6778 6784